Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Revolade
Active Ingredient: Eltrombopag olamine 31.9mg equivalent to eltrombopag 25mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers: Glaxo Operations UK Limited t/a Glaxo Wellcome Operations, Ware, United Kingdom
Lek Pharmaceuticals d.d., Ljubljana, Slovenia
Siegfried Barbera SL, Barcelona, Spain
   
Product: Revolade
Active Ingredient: Eltrombopag olamine 63.8mg equivalent to eltrombopag 50mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers: Glaxo Operations UK Limited t/a Glaxo Wellcome Operations, Ware, United Kingdom
Lek Pharmaceuticals d.d., Ljubljana, Slovenia
Siegfried Barbera SL, Barcelona, Spain
   
Product: Revolade
Active Ingredient: Eltrombopag olamine 95.7mg equivalent to eltrombopag 75mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers: Glaxo Operations UK Limited t/a Glaxo Wellcome Operations, Ware, United Kingdom
Lek Pharmaceuticals d.d., Ljubljana, Slovenia
Siegfried Barbera SL, Barcelona, Spain
   
Product: Zeposia (Combination product)
Component 1  
Active Ingredient: Ozanimod 0.23mg equivalent to ozanimod hydrochloride 0.25mg
Dosage Form: Capsule
Component 2  
Active Ingredient: Ozanimod 0.46mg equivalent to ozanimod hydrochloride 0.5mg
Dosage Form: Capsule
New Zealand Sponsor: Celgene Limited
Manufacturers: Patheon Inc, Mississauga, Canada
Celgene International Sarl, Boudry, Switzerland
   
Product: Zeposia
Active Ingredient: Ozanimod 0.92mg equivalent to ozanimod hydrochloride 1mg
Dosage Form: Capsule
New Zealand Sponsor: Celgene Limited
Manufacturers: Patheon Inc, Mississauga, Canada
Celgene International Sarl, Boudry, Switzerland


Dated this 7th day of July 2023.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).